Treatment with TNF-α inhibitors have been reported to increase reactivation of concurrent chronic hepatitis B and potentially increase hepatitis C virus (HCV) replication7, further supporting the importance of TNF-α in defending the human body against viral infections. The gene discussed is TNF; the disease is viral infectious disease.